tiprankstipranks
Verastem (VSTM)
NASDAQ:VSTM
US Market
VSTM
Verastem
RESEARCH TOOLSreports

Verastem (VSTM) Stock News & Sentiment

2,007 Followers
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
Premium
Ratings
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
11h ago
VSTM
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
Premium
Ratings
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
1M ago
VSTM
Verastem Earnings Call: Early Momentum, Long Runway Risks
Premium
Company Announcements
Verastem Earnings Call: Early Momentum, Long Runway Risks
1M ago
VSTM
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
Premium
Ratings
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
1M ago
VSTM
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
Premium
Ratings
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
1M ago
VSTM
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
Premium
Company Announcements
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
1M ago
8K
VSTM
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
Premium
Market News
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
1M ago
UPB
VERA
More VSTM News >

VSTM News on the Web

Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
TipRanks News
Bullish
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
TipRanks News
Bullish
RBC Capital Sticks to Their Buy Rating for Verastem (VSTM)
TipRanks News
Neutral
Stonepine Capital Management, LLC's Strategic Acquisition of Curis Inc Shares
GuruFocus News
Neutral
Verastem assumed with a Buy at Jefferies
TipRanks News
Bullish
Verastem management to meet with Cantor
TipRanks News
Bullish
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
Zacks
Bullish
Mizuho Securities Remains a Buy on Verastem (VSTM)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
VSTM
Sector Average
Media Buzz
This Week3 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VSTM’s Media Buzz Sentiment?
3 articles about VSTM were published this week. In an average week, 2 articles are published.
    What is VSTM’s weekly average amount of articles?
    In an average week, 2 articles about VSTM are published.
      What is VSTM’s News Sentiment?
      100% of articles about VSTM were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week